SS Innovations International In (SSII) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

SS Innovations International In

NasdaqCM•Healthcare•Medical Devices

$3.41+0.02(0.01%)Market closed

Market Cap

$662.45M

P/S

12.6x

P/B

12.4x

SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally. It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems. The company also develops NADI Automated Coronary Anastomotic Connector, a micro stapling device; SSi Multi-Fire Clip Applier, a cartridge-based clip applicator; SSi Robotic Stapler; SSi Maya is an enabling digital platform that compliments the SSI Mantra system and enhances surgical capabilities; SSi Guru is a virtual tele illustration; SSi XR Cognitive Skill Simulator is an extended reality (XR) software platform developed to train and educate surgeons and surgical assistants; SSi MantraM; SSi Mantra Tele Surgeon Console (TSC); and 5mm surgical instruments; SSi Holographic Anatomy, an augmented reality tool; SSi Chitrasa Advanced DICOM Viewer, an AI enabled application viewer; and SSi Mixed Reality Headset, a medical-grade device. In addition, it offers instrument tips, including forceps, scissors, electrocautery tools, scalpels, and other surgical tools. Further, the company provides accessory products, such as sterile drapes, 3d stereo endoscopes, cannulas, and seals, as well as tele proctoring and telesurgery products. Additionally, it offers installation, repair, maintenance, 24/7 technical support, and proactive health monitoring services. The company sells its products through direct sales organizations and distributor networks. SS Innovations International, Inc. is headquartered in Gurugram, India.

How this company scores

WeakMetricSide Score: 48/100

Grade capped at D — Interest coverage below 1× (-6.0x) — earnings cannot cover interest. Strongest: Growth (20/25); weakest: Balance Sheet & Red Flags (7/25).

Profitability13/25

Growth20/25

Balance Sheet & Red Flags7/25

Cash & Earnings Quality8/25

Strengths

Growing revenueCash-backed earningsProfit converts from growthConsistent growth

Grade capped at D

Interest coverage below 1× (-6.0x) — earnings cannot cover interest.

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/S · 12.6x5y range 12.6x – 70.3x

Currently below its 7-quarter median.

P/B · 12.4x5y range 12.4x – 2427.3x

Currently below its 16-quarter median.

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Red Flag

Free cash flow has been negative in 8 of the last 8 quarters — earnings are not translating to cash.

Price & Volume

Market Cap $662.45M

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $52.40M
Q. Revenue: $13.94M
TTM EBITDA: $-7.00M
TTM Op. Income: $-8.28M
Q. Op. Income: $-2.27M
TTM Net Income: $-12.43M
Q. Net Income: $-2.66M
EPS: $-0.01
Shares Out.: $200.14M

$52.40M in TTM revenue grew 46.5% YoY, reaching $13.94M last quarter. TTM EBITDA of $-7.00M and TTM operating income of $-8.28M show growth is flowing through to the bottom line. However, net income is negative at $12.43M — growth is not yet reaching the bottom line. Across the last 8 quarters, TTM revenue has risen for 2 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 50.9%
EBITDA Margin: -13.8%
Op. Margin: -16.3%
Net Margin: -19.1%

Op. margin of -16.3% is down 17.3% YoY — costs are rising relative to revenue. Net margin at -19.1% and gross margin of 50.9% show how much of each revenue dollar survives to profit. Over the past year, operating margin is down 1780% — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: N/A
P/S Ratio: 12.6x
P/B Ratio: 12.4x

P/S of 12.6x and P/B of 12.4x. P/S is high, meaning growth expectations are priced in.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $96.98M
Cash: $13.65M
Long-Term Debt: N/A
Book Value: $53.40M
D/E Ratio: N/A
Debt/EBITDA: N/A

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $-4.23M
TTM Free Cash Flow: $-18.06M
FCF Margin: -34.5%
FCF / Net Income: 1.5

TTM FCF of $-18.06M on $-4.23M in operating cash flow. The FCF / Net Income ratio of 1.5x means free cash flow covers net income — earnings are backed by cash. Over the past year, free cash flow is down 4% — a weakening trend.